在糖尿病患者队列中,使用便弹性酶测试和PEI评分系统查未诊断的胰腺外分泌功能不足 (PEI)
V Parihar1,2, R Ballester3, P F Ridgway4
1Department of Gastroenterology, Tallaght University Hospital, TallaghtDublin 24, Ireland. Vikpar37@yahoo.com.
Acta diabetologica
|May 26, 2024
概括
一项研究发现,12%的糖尿病患者患有未诊断的胰腺外分泌功能不全 (PEI). 这突显了潜在的健康负担,因为PEI-S症状得分在这个群体中没有有效诊断PEI.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 1型和2型糖尿病 (DM) 经常与胰腺外分泌功能不全 (PEI) 相关.
- 糖尿病患者PEI的确切患病率和临床影响尚不清楚.
- 现有的研究表明PEI患病率的变化取决于诊断方法.
研究的目的:
- 通过便弹性酶-1 (FE-1) 试验,确定糖尿病队列中PEI的患病率.
- 为了验证患者报告的症状评分系统 (PEI-S) 对糖尿病患者的PEI诊断.
主要方法:
- 从大学医院诊所招募了233名糖尿病患者.
- 便弹性酶-1 (FE-1) 测定和PEI症状评分 (PEI-S) 用于诊断.
- PEI是由FE-1<200μg/g或PEI-S>0.6.6定义的
主要成果:
- 在166名返回便样本的患者中,12%的患者根据FE-1水平出现PEI.
- 在这种糖尿病人群中,吸烟被确定为PEI的危险因素.
- PEI-S系统没有有效地区分正常和低FE-1水平的糖尿病患者.
结论:
- 未诊断的PEI影响了1型和2型DM患者这一现实世界队列的12%.
- 2型DM的患病率上升表明PEI的重大,未被认可的负担具有潜在的长期健康后果.
- 在这种糖尿病患者群体中,PEI-S症状评分系统表现不佳.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
84
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
84
Serum Laboratory Studies, Stool Test, Breath Test
334
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
334
Ultrasound II: Endoscopic Ultrasound and FibroScan
98
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
98
Endoscopic Procedures V: ERCP
190
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
190


